Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder for injection, concentrated pills, tablets, capsules, gelatins, ointments, creams, granules, etc. The company provides drugs in various categories, including antibiotics, gastrointest… Read more
Youcare Pharmaceutical Group Co. Ltd. A (688658) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.80 Billion CNY
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has total liabilities worth CN¥1.80 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Youcare Pharmaceutical Group Co. Ltd. A - Total Liabilities Trend (2017–2024)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Toyo Ink SC Holdings Co. Ltd
F:TO5
|
Germany | €182.50 Billion |
|
Taiheiyo Cement Corp
PINK:THYCY
|
USA | $754.73 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥136.22 Million |
|
NB Bancorp, Inc. Common Stock
NASDAQ:NBBK
|
USA | $6.15 Billion |
|
Investors Real Estate Trust
F:WXC1
|
Germany | €1.21 Billion |
|
Guangzhou Wondfo Biotech Co Ltd
SHE:300482
|
China | CN¥1.09 Billion |
|
DINE S.A.B. de C.V
MX:DINEB
|
Mexico | MX$4.38 Billion |
|
Transcat Inc
NASDAQ:TRNS
|
USA | $176.12 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Youcare Pharmaceutical Group Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Youcare Pharmaceutical Group Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Youcare Pharmaceutical Group Co. Ltd. A (2017–2024)
The table below shows the annual total liabilities of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.15 Billion | -6.94% |
| 2023-12-31 | CN¥2.31 Billion | +15.03% |
| 2022-12-31 | CN¥2.01 Billion | +11.76% |
| 2021-12-31 | CN¥1.80 Billion | -3.82% |
| 2020-12-31 | CN¥1.87 Billion | -20.12% |
| 2019-12-31 | CN¥2.34 Billion | -9.05% |
| 2018-12-31 | CN¥2.58 Billion | -7.77% |
| 2017-12-31 | CN¥2.79 Billion | -- |